Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C21H30O2 |
| Molecular Weight | 314.4617 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCCC1=CC(O)=C2C=CC(C)(CCC=C(C)C)OC2=C1
InChI
InChIKey=UVOLYTDXHDXWJU-UHFFFAOYSA-N
InChI=1S/C21H30O2/c1-5-6-7-10-17-14-19(22)18-11-13-21(4,23-20(18)15-17)12-8-9-16(2)3/h9,11,13-15,22H,5-8,10,12H2,1-4H3
| Molecular Formula | C21H30O2 |
| Molecular Weight | 314.4617 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Neurophysiological and subjective profile of marijuana with varying concentrations of cannabinoids. | 2005 Sep |
|
| Cannabinoids in the management of difficult to treat pain. | 2008 Feb |
|
| Evaluation of prevalent phytocannabinoids in the acetic acid model of visceral nociception. | 2009 Nov 1 |
|
| Thermal isomerization of cannabinoid analogues. | 2009 Nov 25 |
|
| Pharmacological evaluation of the natural constituent of Cannabis sativa, cannabichromene and its modulation by Δ(9)-tetrahydrocannabinol. | 2010 Nov 1 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:04:43 GMT 2023
by
admin
on
Fri Dec 15 15:04:43 GMT 2023
|
| Record UNII |
K4497H250W
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
CANNABICHROMENE
Created by
admin on Fri Dec 15 15:04:43 GMT 2023 , Edited by admin on Fri Dec 15 15:04:43 GMT 2023
|
PRIMARY | |||
|
2585216
Created by
admin on Fri Dec 15 15:04:43 GMT 2023 , Edited by admin on Fri Dec 15 15:04:43 GMT 2023
|
PRIMARY | |||
|
291831
Created by
admin on Fri Dec 15 15:04:43 GMT 2023 , Edited by admin on Fri Dec 15 15:04:43 GMT 2023
|
PRIMARY | |||
|
C010695
Created by
admin on Fri Dec 15 15:04:43 GMT 2023 , Edited by admin on Fri Dec 15 15:04:43 GMT 2023
|
PRIMARY | |||
|
DTXSID80942873
Created by
admin on Fri Dec 15 15:04:43 GMT 2023 , Edited by admin on Fri Dec 15 15:04:43 GMT 2023
|
PRIMARY | |||
|
DB14735
Created by
admin on Fri Dec 15 15:04:43 GMT 2023 , Edited by admin on Fri Dec 15 15:04:43 GMT 2023
|
PRIMARY | |||
|
K4497H250W
Created by
admin on Fri Dec 15 15:04:43 GMT 2023 , Edited by admin on Fri Dec 15 15:04:43 GMT 2023
|
PRIMARY | |||
|
30219
Created by
admin on Fri Dec 15 15:04:43 GMT 2023 , Edited by admin on Fri Dec 15 15:04:43 GMT 2023
|
PRIMARY | |||
|
20675-51-8
Created by
admin on Fri Dec 15 15:04:43 GMT 2023 , Edited by admin on Fri Dec 15 15:04:43 GMT 2023
|
PRIMARY | |||
|
K4497H250W
Created by
admin on Fri Dec 15 15:04:43 GMT 2023 , Edited by admin on Fri Dec 15 15:04:43 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> ACTIVE CONSTITUENT ALWAYS PRESENT |
Anti-inflammatory | Antibiotic | Antifungal | Analgesic
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
